unknown
Stage
About
Elgan Pharma is a late-stage neonatology-focused biotech company developing safe, non-invasive therapies for preterm infants to address complications related to prematurity, including treatments for intestinal malabsorption and prevention of vision impairment due to retinopathy of prematurity.
Explore Elgan Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.